Biogenesis, IncFebruary 27, 2025

FDA 483 - Biogenesis, Inc - February 27, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biogenesis, Inc

Record Details

Biogenesis, Inc. in Paterson, NJ, an OTC drug manufacturer, received an FDA Form 483 with one observation. The inspection found that equipment was not cleaned at appropriate intervals, specifically noting white powder residue on a kettle labeled as "Clean" that is used for manufacturing various OTC drug products. This condition indicates a potential risk of contamination to drug products.

Company: Biogenesis, Inc
Inspection Date: February 27, 2025
Product Type: Drugs
Office: New Jersey District Office
People: Amatul H. Marium
Raihan A. Chowdhury

Open in Dashboard

ID · 1c2a5a5a-c07f-4e44-bd2a-c8607e8fe6a2